ISRCTN05568900已完成不适用
Prospective study on the effects of rituximab on synovial tissue of patients with rheumatoid arthritis
Academic Medical Centre (AMC) (The Netherlands)0 个研究点目标入组 32 人开始时间: 2007年6月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients (18 years or older) with rheumatoid arthritis (American College of Rheumatology [ACR] 1987 criteria) with active disease (at least 4/28 swollen and at least 4/28 painful joints, and either Erythrocyte Sedimentation Rate [ESR] 28 mm or C-Reactive Protein [CRP] 15 mg/l or morning stiffness for 45 minutes)
- •2. Rheumatoid factor and/or anti-Cyclic Citrullinated Peptide antibody (anti-CCP) positive
- •3. Stable doses of methotrexate (5 - 30 mg)
- •4. Stable doses of prednisone (0 - 10 mg)
- •5. Previous anti-Tumour Necrosis Factor (anti-TNF) treatment is allowed
排除标准
- •1. Previous treatment with rituximab
- •2. Intra-articular or parenteral corticosteroids within four weeks prior to inclusion
研究者
相似试验
已完成
不适用
Prospective study on the effects of rituximab on synovial tissue of patients with rheumatoid arthritis.rheumatoid arthritisNL-OMON19978Academic Medical Center/University of Amsterdam32
已完成
不适用
A study of the efficacy and safety to rituximab in treating adult onset refractory nephrotic syndromeRefractory nephrotic syndromeJPRN-UMIN000021143Fujita Health University School of Medicine, Department of Nephrology10
未知
2 期
Clinical study for effectiveness of rituximab for acquired coagulopathyacquired coagulopathyJPRN-UMIN000024612Gunma University10
进行中（未招募）
不适用
Impact d'un traitement par le rituximab sur l'évolution des rejets aigus humoraux après transplantation rénale - MabTherarejet aigu humoral (RAH) après transplantation rénaleEUCTR2007-003213-13-FRCHRU-Tours
进行中（未招募）
1 期
Efficacy and safety of rituximab in the treatment of good prognosis microscopic polyangiitisEUCTR2018-000637-12-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)106